Stem Cell Technology Goes From Lab To Bedside
Dr. Allan Wu helped delegates understand trends in stem cell-based clinical practice.
Leaders in stem cell research and clinical utilization converged on Rancho Las Palmas Resort & Spa in Rancho Mirage for the Select Bioscience’s Clinical Translation of Stem Cells Summit, hosted by Dr. David Morrow, founder and director of The Morrow Institute.
“This summit continues The Morrow Institute’s efforts that began in 2008, when we hosted the first mini-summit on biotech research held in the Coachella Valley,” Morrow says. “The field has advanced so far in a short amount of time. This conference provided the opportunity for participants to look beyond research to practical issues.”
In his keynote address, Dr. Allan Wu, co-founder of The Morrow Institute’s Non-Controversial Stem Cell Research Lab, addressed trends in bringing stem cells from the research bench to the bedside. He also led clinical practicums focused on harvesting adipose derived stem cells in the clinical setting, and providing delegates a realtime, hands-on opportunity to understand trends in stem cell-based clinical practice.
Other presenters covered the stem cell therapy industry, use of stem cells in brain tumor trials, ethical issues, the use of stem cells in fat transfer, and guided imagery in stem cell injections. They also established a compliant regenerative medical surgical organization. Additional sessions included cell-assisted lipotransfer, the use of adult stem cells in the treatment of disease, the future of cellbased personalized medicine, stem cells in age-related macular degeneration, and the impact of policy on clinical trials.
The Morrow Institute — an accredited outpatient plastic, reconstructive, and cosmetic surgery center — is also an FDA-registered stem cell research laboratory and tissue bank.
Contact The Morrow Institute at 760-202-2770.